Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: The double-blind placebo-controlled moscow study

[No abstract available]

Редакторы
-
Журнал
Издательство
-
Номер выпуска
2
Язык
Английский
Страницы
-
Статус
Опубликовано
Подразделение
-
Номер
-
Том
185
Год
2011
Организации
  • 1 Department of Endocrinology, Faculty of Medical Staff Refresher Training, People's Friendship University of Russia, Moscow, Russian Federation
Ключевые слова
C reactive protein; cholesterol; glucose; high density lipoprotein cholesterol; insulin; interleukin 10; interleukin 1beta; interleukin 6; leptin; low density lipoprotein cholesterol; placebo; testosterone undecanoate; triacylglycerol; tumor necrosis factor alpha; adult; aged; androgen therapy; body mass; body weight; disease association; double blind procedure; drug efficacy; human; hypogonadism; inflammation; major clinical study; male; metabolic syndrome X; note; outpatient department; phase 3 clinical trial; priority journal; randomized controlled trial; Russian Federation; testosterone blood level; therapy effect; treatment duration; waist circumference
Дата создания
19.10.2018
Дата изменения
19.10.2018
Постоянная ссылка
https://repository.rudn.ru/ru/records/article/record/2589/